Osteotech Reports 4.5% Decline in Third Quarter Revenue

Osteotech experienced a 4.5% decline in revenue in the third quarter compared with the same period last year, according to a release from Osteotech.

Advertisement

The company attributed the drop to expected revenue declines in client services and private label demineralized bone matrix.

Read the release on Osteotech’s third-quarter revenues.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.